Codes / ICD10CM / B46.3

B46.3 Cutaneous mucormycosis

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Cutaneous mucormycosis
  • ICD-10 Code: B46.3

Summary

Cutaneous mucormycosis is a rare fungal infection affecting the skin, caused by organisms in the order Mucorales. It typically occurs in individuals with weakened immune systems or after skin trauma, leading to localized skin lesions that may progress if not treated promptly.

Causes

Cutaneous mucormycosis is caused by fungi in the order Mucorales, which are found in soil, decaying organic matter, and sometimes in hospital environments. Infection occurs when spores enter the body through breaks in the skin, such as wounds, burns, or surgical sites. These fungi thrive in environments with high glucose levels, posing a risk for individuals with uncontrolled diabetes.

Risk Factors

  • Weakened immune system (e.g., from chemotherapy, organ transplant, or HIV/AIDS)
  • Uncontrolled diabetes mellitus
  • Prolonged corticosteroid use
  • Skin trauma or burns
  • Intravenous drug use
  • Malnutrition or iron overload

Symptoms

  • Skin lesions that may appear as nodules, plaques, or ulcers
  • Lesions that become necrotic (blackened or dead tissue)
  • Pain or tenderness at the affected site
  • Swelling or redness around the lesion
  • Fever (in severe cases)

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging (e.g., MRI or CT scans) to assess tissue involvement, and laboratory tests. Tissue samples are examined microscopically and cultured to identify the fungal species, confirming the presence of Mucorales.

Treatment Options

Treatment includes antifungal medications (e.g., amphotericin B) and surgical debridement to remove infected tissue. Early intervention is critical to prevent spread. Supportive care, such as managing underlying conditions (e.g., diabetes), is also essential.

Prognosis and Follow-Up

Prognosis depends on the extent of infection, immune status, and timeliness of treatment. Early diagnosis and aggressive therapy improve outcomes. Follow-up includes monitoring for recurrence and managing underlying risk factors.

Complications

  • Spread of infection to deeper tissues or bloodstream (disseminated mucormycosis)
  • Tissue necrosis requiring extensive surgical removal
  • Permanent scarring or disfigurement
  • Severe systemic illness in immunocompromised patients

Lifestyle & Prevention

  • Keep skin clean and intact; promptly treat wounds or burns.
  • Manage underlying conditions (e.g., diabetes) to reduce susceptibility.
  • Avoid contact with soil or decaying matter if immunocompromised.
  • Follow healthcare provider guidance for wound care and hygiene.

When to Seek Professional Help

Seek immediate medical attention if you have skin lesions that worsen, become necrotic, or are accompanied by fever, especially if you have a weakened immune system or uncontrolled diabetes.

Tips for Medical Coders

Document the specific site of cutaneous involvement (e.g., trunk, extremities) and any associated risk factors (e.g., diabetes, immunosuppression) to support accurate coding. Ensure clinical documentation aligns with the diagnosis and treatment provided.

Book a walkthrough

B46.3 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.